Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-26-022631

Chief Financial Officer gave up 507 shares (to pay taxes)

  • Chief Financial Officer acquired 1,228 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Vu Quan Anh · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-30 Exercise or conversion : show line 1 in the form +1,228 2,728 D
2026-06-30 Shares withheld for taxes : show line 2 in the form −507 $92.59 $46,943 2,221 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-30 Exercise or conversion : show line 3 in the form Restricted Stock Unit −1,228 8,598 D
Loading xslF345X06/rdgdoc.xml…